John Jui-Jen Lee is Chief Development Officer of Decibel Therapeutics, Inc.
Person profile
Roles
Decibel Therapeutics
Chief Development Officer
Address
Boston, Massachusetts
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
25 Sep 23 | DBTX Decibel Therapeutics | Common Stock | Sale back to company | Dispose D | No | No | 0 | 147,144 | 0.00 | 0 |
25 Sep 23 | DBTX Decibel Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 4.4 | 232,003 | 1.02 mm | 0 |
25 Sep 23 | DBTX Decibel Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 3.5 | 52,500 | 183.75 k | 0 |
25 Sep 23 | DBTX Decibel Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 3.12 | 45,000 | 140.40 k | 0 |
26 Jan 23 | DBTX Decibel Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 120,000 | 0.00 | 147,144 |
26 Jan 23 | DBTX Decibel Therapeutics | Stock Options Common Stock | Grant | Acquire A | No | No | 3.12 | 45,000 | 140.40 k | 45,000 |